NCT07038941View on ClinicalTrials.gov

Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

June 2, 2024

Study Completion Date

June 2, 2024

Conditions
Male Pattern of Hair Loss, Androgenic AlopeciaAndrogenetic Alopecia (AGA)
Interventions
DRUG

CG2001

combination of minoxidil and finasteride

DRUG

Placebo foam

Placebo foam

Trial Locations (1)

Unknown

Peking University People's Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Beijing Dayspring Pharmaceutical Technology Co., Ltd

INDUSTRY

NCT07038941 - Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia | Biotech Hunter | Biotech Hunter